BioSpace News Archive

BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), today announced that, in light of the significant demands placed on her time by a number of other business commitments, Dr. Nancy Stagliano has resigned as a director of the company

Iron Deficiency Day is an international event which raises awareness of the serious impact of iron deficiency and iron deficiency anaemia

Deep 6 AI, the leading provider of clinical trials acceleration software, announced today that it has raised $17M in Series A funding led by Point72 Ventures, with GSR Ventures and strategic partners participating.

Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain diseases, today announced that Brad Margus, chief executive officer, will present the company’s target discovery and clinical development work during the 31st Annual Piper Jaffray Healthcare Conference taking place December 3-5, 2019 in New York, NY.

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the Piper Jaffray 31st Annual Healthcare Conference

Medical Economics®, a multimedia platform that provides resources for physicians that include practice management tips, health technology and expert voices, announced three winners of the 2019 Medical Economics® Physician Writing contest.

Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., in conjunction with SpineThera, Inc., today announced the first dose administered in the SALIENT (Safety and Efficacy of SX600 Administered by Lumbosacral Transforaminal Epidural Injection for Radicular Pain) Phase 1/2 clinical study of SX600, a non-opioid epidural steroid injection in development for the treatment of sciatica

Synaptive Medical, a leader in automation and robotics, announced today it will highlight its products EvryTM, Modus PlanTM and ImageDriveTM at the Radiological Society of North America’s (RSNA) 2019 Scientific Assembly and Annual Meeting, which will convene at McCormick Place in Chicago, IL, from December 1-6.

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating protein expression, today announced that Chief Executive Officer Edward M. Kaye, M.D., will present at the Piper Jaffray 31st Annual Healthcare Conference on Wednesday, December 4, 2019 at 11:50 a.m. ET in New York, NY.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of James R. Meyers, an accomplished pharmaceutical executive with three decades of commercial experience, to the Company’s Board of Directors.